← Back to Patent Explorer
US4148786A Expired / Lapsed US ⏱️ 0.0 years remaining

Analgesic polypeptide

Assignee: Wyeth LLC
•
Filing: 1978-06-26
•
Granted: 1979-04-10
•
Expires: 1998-06-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The polypeptides of the formula: ##STR1## in which R 1 is hydrogen, lower alkyl, allyl, 2-isopentenyl, 3-isopentenyl, cyclopropylmethyl, cyclobutylmethyl, phenethyl or arginyl; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; R 4 is hydrogen, hydroxymethyl, carbo(lower)alkoxy, carbamyl or carboxy; and X is hydrogen, chloro, fluoro, bromo or iodo, the linear precursors thereof or a pharmaceutically acceptable salt thereof, Exert an analgesic effect in warm-blooded animals when peripherally administered.

Inventors

  • 👤 Dimitrois Sarantakis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 04:33
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/665; C07K14/70; C07K14/702; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/28

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 64 words
A polypeptide of the formula: ##STR4## in which R 1 is hydrogen, lower alkyl, allyl, 2-isopentenyl, 3-isopentenyl, cyclopropylmethyl, cyclobutylmethyl, phenethyl or arginyl; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; R 4 is hydrogen, hydroxymethyl, carbo(lower)alkoxy, carbamyl or carboxy; and X is hydrogen, chloro, fluoro, bromo or iodo; the linear precursors thereof or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 64 words
A polypeptide of the formula: ##STR4## in which R 1 is hydrogen, lower alkyl, allyl, 2-isopentenyl, 3-isopentenyl, cyclopropylmethyl, cyclobutylmethyl, phenethyl or arginyl; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; R 4 is hydrogen, hydroxymethyl, carbo(lower)alkoxy, carbamyl or carboxy; and X is hydrogen, chloro, fluoro, bromo or iodo; the linear precursors thereof or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 21 words
A compound of claim 1 which is Tyr-D-Cys-Gly-Phe-D-Cys-NH 2 cyclic (2-5) disulfide, its linear precursor or a pharmaceuticaly acceptable salt thereof.
Claim 4
Dependent Claim 21 words
A compound of claim 1 which is Tyr-D-Cys-Gly-Phe-Cys-NH 2 cyclic (2-5) disulfide, its linear precursor or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 21 words
A compound of claim 1 which is Tyr-D-Cys-Gly-N-methyl-Phe-D-Cys-NH 2 cyclic (2-5) disulfide, its linear precursor or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 21 words
A compound of claim 1 which is Arg-Tyr-D-Cys-Gly-Phe-D-Cys-NH 2 cyclic (3-6) disulfide, its linear precursor or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 21 words
A compound of claim 1 which is N-methyl-Tyr-D-Cys-Gly-Phe-D-Cys-NH 2 cyclic (2-5) disulfide, its linear precursor or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 63 words
A compound of the formula: ##STR5## in which R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; X is hydrogen, chloro, bromo, fluoro or iodo; A is hydrogen, an α-amino protecting group or α-amino protected, N-guanyl protected arginyl; F is a phenolic hydroxy protecting group; D is a mercapto protecting group; and E is a mercapto protecting group.
Claim 9
Dependent Claim 63 words
A compound of the formula: ##STR5## in which R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; X is hydrogen, chloro, bromo, fluoro or iodo; A is hydrogen, an α-amino protecting group or α-amino protected, N-guanyl protected arginyl; F is a phenolic hydroxy protecting group; D is a mercapto protecting group; and E is a mercapto protecting group.
Claim 10
Dependent Claim 24 words
A compound of claim 7 in which A is tert-butyloxycarbonyl-(N g -NO 2 )Arg, F is 2,6-dichlorobenzyl, D is p-methoxybenzyl and E is p-methoxybenzyl.
Claim 11
Dependent Claim 20 words
A compound of claim 7 in which A is tert-butyloxycarbonyl, F is 2,6-dichlorobenzyl, D is p-methoxybenzyl and E is p-methoxybenzyl.

References Cited (Backward Citations)

US4028319A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-04-09 1982-10-09 1983-04-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-04-09 1986-10-09 1987-04-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-04-09 1990-10-09 1991-04-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag